Lithium Universe Ltd (ASX:LU7, OTC:LUVSF) has expanded its collaboration with Macquarie University by appointing Mohammadreza Hojati to the photovoltaic (PV) recycling research team, strengthening mechatronics and robotics capability across Microwave Joule Heating Technology (MJHT) and Jet Electrochemical Silver Extraction (JESE). The hire aims to maintain development momentum and support future scaling to the company’s planned Texas PV recycling facility.
“Mr Hojati brings exceptional experience in robotics, motor design and system optimisation — skills that directly translate into greater precision and efficiency within our Microwave Joule Heating Technology (MJHT) and Jet Electrochemical Silver Extraction (JESE) Technology system,” executive chairman Iggy Tan said.
374Water Inc (NASDAQ:SCWO) announced that its board of directors has appointed Stephen Jones as interim president and CEO.
Jones, who joined 374Water’s board in June 2025, will oversee the company’s current project deployments, the commercialization of its super critical water oxidation (SCWO) technology, and the accelerated conversion of its growing pipeline of opportunities.
Arizona Gold & Silver Inc (TSX-V:AZS, OTCQB:AZASF) has reported high-grade antimony results from its Silverton gold-antimony project in Nye County, Nevada.
Sampling across stibnite-quartz veins and surrounding rock returned antimony grades up to 7.95% from a 25.4-centimeter-wide vein, with an average of 1.38% across 14 samples, including non-vein material.
Analysts at Research Capital see a recent update from Alvopetro Energy Ltd (TSX-V:ALV, OTC:ALVOF) supporting their growth outlook for the natural gas firm with assets in Brazil and Canada.
On Wednesday, Alvopetro Energy reported average September sales of 2,231 boepd, driven by strong production from its Murucututu field in Brazil and early output from new wells in Canada’s Big Gully project.
Lisata Therapeutics Inc (NASDAQ:LSTA) announced that it has entered into a global product license agreement with Catalent, which would allow Catalent to incorporate Lisata's certepetide into antibody-drug conjugates (ADCs) developed using Catalent’s SMARTag technology platform.
The clinical-stage pharmaceutical company said Certepetide, a proprietary, internalizing RGD (arginyl-glycyl-aspartic acid), or “iRGD” cyclic peptide, is being tested by Lisata as a cancer therapeutic to be used in combination with other anti-cancer agents to enhance tumor targeting and penetration and improve treatment outcomes.
Gunnison Copper Corp (TSX:GCU, OTCQB:GCUMF) has announced preliminary results from an independent Economic Impact Study conducted by the Eller Partnerships Office at the University of Arizona, projecting multi-billion-dollar economic benefits associated with the company’s Gunnison Copper Project in southern Arizona.
According to Gunnison, the study used nationally accepted economic modeling tools to assess cumulative potential impacts at the national, state, and county levels.
First Phosphate Corp. (CSE:PHOS, OTCQX:FRSPF) announced that the Honourable Timothy Hodgson, Canada's Minister of Energy and Natural Resources, MP Claude Guay, Parliamentary Secretary to the Minister of Energy and Natural Resources, and Members of Parliament (MPs) Mario Simard and Richard Martel visited the planned site of the company’s future phosphoric acid plant at Port Saguenay in Quebec on October 4, 2025, during Minister Hodgson and Parliamentary Secretary Guay's tour of the region.
The mineral development company said the ministerial visit highlights the potential role of First Phosphate's high-purity igneous phosphate project in Canada's energy transition and in the sustainable development of a North American supply chain for lithium iron phosphate (LFP) batteries.
GoviEx Uranium Inc (TSX-V:GXU, OTCQB:GVXXF) announced that shareholders of Tombador Iron Limited have approved all resolutions required to move forward with the proposed reverse takeover of Tombador by GoviEx.
At a general meeting held on October 8, Tombador shareholders passed the necessary resolutions, including the issuance of consideration shares to GoviEx shareholders, replacement options for GoviEx optionholders and warrantholders, and a change of company name to Atomic Eagle Ltd.
Bit Digital Inc (NASDAQ:BTBT) announced that it acquired 653 Ethereum (ETH) in September 2025.
The digital asset platform said its total average ETH acquisition price for all its holdings was $2,643.27 per ETH.
Alvopetro Energy Ltd (TSX-V:ALV, OTC:ALVOF) has reported average September sales volumes of 2,231 barrels of oil equivalent per day (boepd), alongside updates on its natural gas pricing, a non-core asset sale in Brazil, and expansion of its exploration portfolio in Western Canada.
In Brazil, the company’s September sales averaged 2,069 boepd, including 11.3 million cubic feet per day (MMcfpd) of natural gas, 180 barrels per day (bopd) of condensate, and 9 bopd of oil.
Conroy Gold and Natural Resources PLC (AIM:CGNR, OTC:CGDNF) saw its shares rise sharply after it confirmed a previously announced private placing was oversubscribed.
It raised £1.73 million from new and existing shareholders, with the new shares priced at 10p.
Oxford BioDynamics PLC (AIM:OBD, OTC:OXBOF) shares surged 33% on Wednesday after the company announced it had developed a highly accurate blood test to diagnose Chronic Fatigue Syndrome, a condition that has long lacked a reliable means of detection.
The AIM-listed diagnostics firm said the test, created with researchers at the University of East Anglia, achieved 96% accuracy in identifying the condition, also known as Myalgic Encephalomyelitis, or ME. The peer-reviewed results have been published in the Journal of Translational Medicine.
Oxford BioDynamics PLC (AIM:OBD, OTC:OXBOF) has developed what it calls a “first-in-class” blood test to diagnose Chronic Fatigue Syndrome, a breakthrough that could help end years of uncertainty for patients struggling to obtain a clear diagnosis.
The AIM-listed diagnostics company said the test, created with researchers at the University of East Anglia, achieved 96% accuracy in identifying the condition, also known as Myalgic Encephalomyelitis, or ME. The findings have been published in the Journal of Translational Medicine.
ANGLE PLC (AIM:AGL, OTCQX:ANPCY), the cancer diagnostics group behind the Parsortix blood testing platform, is changing its name to CelLBxHealth and adopting a tighter commercial focus as it seeks to strengthen its finances and accelerate growth.
Dr Jan Groen, currently non-executive chairman, has stepped into an executive role to lead the reshaped company.
Pantheon Resources PLC (AIM:PANR, OTCQX:PTHRF) has successfully completed hydraulic fracture stimulation operations at the Dubhe-1 well on Alaska’s North Slope.
The 25-stage plug-and-perforate programme was finalised over eight days without safety or environmental incidents, the AIM-quoted company said in a statement.
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF) has secured a fresh $1.8m contract from a leading American self-driving car company, extending its role in the growing autonomous ride-hailing sector.
The Canberra-based company, which makes driver and operator monitoring systems, said the deal would supply more of its Guardian Backup-driver Monitoring System units, known as BdMS, to support the customer’s expanding test fleet across the US.
Elixir Energy Ltd (ASX:EXR, OTC:ELXPF) has intersected a significant overpressured gas column at its Diona-1 exploration well in Authority to Prospect 2077 (Diona sub-block), Surat-Bowen Basin, Queensland, after reaching 2,479 metres (m) of measured depth.
Elixir is fully carried on Diona-1 by Xstate Resources Limited (ASX:XST) under an earlier transaction.